ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2019 American Transplant Congress

June 1-5, 2019 in Boston, MA

View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z
  • ICOS+PD-1+ Circulating T Follicular Helper Cells Are a Biomarker of Humoral Alloreactivity and Predict Donor-Specific Antibody Generation Following Transplantation

    G. M. La Muraglia II, M. E. Wagener, M. L. Ford, I. R. Badell

  • Idarucizumab For The Reversal Of Dabigatran In Patients Undergoing Heart Transplantation

    J. Van Keer1, T. Vanassche1, W. Droogne1, S. Rex2, F. Rega3, J. Van Cleemput1, P. Verhamme1, M. Naesens4

  • Identification and Determinants of Cardiac Allograft Vasculopathy Trajectories after Heart Transplantation

    G. Bonnet1, G. Coutance1, M. Racape1, M. Raynaud1, J. Van keer2, M. Bories1, S. Varnous3, P. Rouvier3, R. Guillemain4, L. Lecuyer4, P. Bruneval4, J. Duong-Van-Huyen1, J. Taupin5, M. Naesens2, C. Lefaucheur1, X. Jouven1, A. Loupy1

  • Identification of Adult Liver Transplant Recipients Eligible to Participate in an Immunosuppression Withdrawal Trial Employing Non-Invasive Assessments of Allograft Status

    J. Vionnet1, R. Miquel1, A. Douiri1, M. Elstad1, E. Kodela1, A. Quaglia2, J. Wall1, P. Ruiz Martin1, E. B. Riani3, J. Leithead4, A. Marshall2, M. Navasa5, P. Ruiz5, J. Ferguson6, K. Simpson7, A. Pascher8, E. Jaeckel9, R. Bishop10, F. Nevens11, S. Masson12, A. Sanchez-Fueyo1

  • Identification of Antibodies Reactive to Vimentin in a Rat Kidney Transplant Model of Chronic Antibody-Mediated Rejection

    S. Reese, N. Wilson, L. Ptak, J. Sullivan, W. Burlingham, A. Djamali, S. E. Panzer

  • Identification Of Pre-transplant Biomarkers Of Recipient Immune Dysfunction That Predict Recipient Risk Of Death Following Liver Transplant: The Immune Frailty Index

    K. E. Lunsford1, N. Aware1, K. Cleveland1, C. J. Manner1, D. T. Nguyen2, E. A. Graviss2, J. V. Thomas1, H. Vyas1, L. W. Moore1, S. A. Dorman1, A. Saharia1, C. M. Mobley1, M. J. Hobeika1, X. C. Li1, R. M. Ghobrial1

  • Identification of Rare Genetic Disorders in Kidney Transplantation Recipients with Un-Diagnosed Nephropathy through NGS Approach

    G. Castellano, M. Giliberti, P. Pontrelli, M. Gigante, S. Diella, M. Accetturo, E. Stea, A. Mitrotti, L. Gesualdo

  • Identification of Relevant Renal Transplant Patient Reported Symptoms That Could Be Used for New Patient Reported Outcome Development

    I. Purnajo1, J. Beaumont1, M. Polinsky2, E. Alemao2, M. J. Everly1

  • Identifying a Clinically Relevant Cut-Off for Height That is Associated with a Higher Risk of Waitlist Mortality in Liver Transplant Candidates

    J. Ge, J. C. Lai

  • Identifying Barriers to Organ Donation among Asians Americans

    M. T. Li, G. C. HIllyer, S. Mohan

  • Identifying the Proverbial “Needle in the Arm” with Natural Language Processing

    G. R. Vece, J. Foutz, A. Placona

  • IE-1 Specific T Cell Receptor Repertoire Diversity and Protection against CMV Reactivation

    M. Lucia Perez1, F. Rubelt1, S. Busque1, C. O. Esquivel1, S. M. Krams1, O. Bestard2, O. M. Martinez1

  • IFNAR Signaling Augments Plasmacytoid Dendritic Cell Activation during Costimulation Independent Rejection

    J. Habib, D. Mathews, Y. Dong, A. Stephenson, A. Ghosh, C. Breeden, A. Adams

  • IgG Glycosylation Causes Podocyte Injury in Transplant Glomerulopathy through Calcium Calmodulin Kinase IV

    R. Bhargava, K. Maeda, M. Pavlakis, G. Tsokos

  • IgG4 Subclass Class 2 Donor Specific Antibody (DSA) is Associated with Subclinical Rejection in Stable Pediatric Liver Transplant (LT) Recipients with Normal Liver Tests

    A. Jackson1, S. Kanaparthi2, B. Burrell3, D. Lucas4, R. Vega4, A. J. Demetris5, S. Feng6

  • Iguratimod Attenuates the Production of Donor Specific Antibody by Inducing CD19+Tim-1+ Regulatory B Cells and Imbalance of Th17 Treg

    Z. Wang, S. Fei, H. Chen, Z. Han, L. Sun, J. Tao, X. Ju, M. Zheng, R. Tan, M. Gu

  • Iguratimod Inhibits the Donor Specific Antibodies Production and Attenuates the Antibody Mediated Rejection in Rat Kidney Transplantation

    Z. Wang, M. Zheng, H. Chen, S. Li, Z. Han, J. Tao, X. Ju, R. Tan, M. Gu

  • Ikaros/IRF4 Signaling Regulates SIRT1-Mediated Macrophage M2 Shift in Liver Ischemia-Reperfusion Injury: From Mouse-to-Human

    K. Kadono1, K. Nakamura1, H. Hirao1, S. Kageyama1, K. J. Dery1, T. Ito1, J. Aziz1, X. Li2, B. Ke1, R. W. Busuttil1, J. W. Kupiec‐Weglinski1

  • IL-10+ Plasma Cells Are Not Required for Breg Activity and Are Counterbalanced by Novel Pro-Inflammatory Plasma Cells

    Q. Ding, Y. Zhou, Z. Song, L. Zeng, D. Rothstein

  • IL-1β and IL-6 Facilitate T Cell Reconstitution in Heart Allograft Recipients Treated with Anti-Thymocyte Globulin

    S. Hasgur, R. Fan, A. Valujskikh

  • IL-21 Induces the Transformation of Th Cell Subsets in Acute Rejection after Kidney Transplantation

    H. Deng, R. Wang, J. Shen, J. Chen

  • IL-6R Blockade with Tocilizumab Increases Tregs and Decreases Early Graft Inflammation in Kidney Transplant Recipients: Results of a Randomized Controlled Trial

    S. Chandran, J. Leung, Z. Laszik, Q. Tang, C. Hu, M. Joanes, F. Vincenti

  • ilearnKAS: An Animated Video to Educate African Americans about Key Concepts of Kidney Allocation

    J. Narvaez, B. Dolph, T. Feeley, L. Kayler

  • Illustration of Renal Recovery in SLK with Utilization of Most Recent Allocation Criteria

    B. Patel, R. Prashar, A. Babu

  • Immediate Post Reperfusion In Vivo Transcriptional Responses of Individual Human Renal Allograft Cell Populations to Circulating Anti-Angiotensin II Type I Receptor Antibody

    C. M. Castro -Rojas1, N. Salomonis2, K. Chetal2, R. R. Alloway3, E. Woodle3, D. A. Hildeman1

  • Immediate Post-Operative Extubation Decreases Pulmonary Complications in Liver Transplant Patients

    M. Safwan, C. Acho, Y. Morita, V. Fernandez, D. Galusca, M. Abouljoud, A. Yoshida, J. El-Bashir, S. Nagai

  • Immune Cell Types and Host Gene Signatures Associated with Epstein-Barr Virus (EBV) Post-Transplant Lymphoproliferative Disorder (PTLD)

    J. Toh1, F. Vallania1, W. A. Haynes1, G. Bhagat2, F. E. Craig3, S. H. Swerdlow4, T. Tousseyn5, S. M. Krams1, P. Khatri1, O. M. Martinez1

  • Immune Cells Composition of Humanized Mouse Kidney Compared to Normal Human Kidney

    S. Noel1, J. T. Kurzhagen1, S. Lee1, M. Sadasivam2, A. R. Hamad2, P. M. Pierorazio3, H. Rabb1

  • Immune Privilege May Predispose Patients after Orthotopic Heart Transplantation to Develop Recipient to Donor Atrial Connections Associated with Atrial Arrhythmias

    B. Herweg1, M. Nellaiyappan1, T. Tran1, G. Mabry1, K. Weston1, H. J. Eisen2, M. Weston3

  • Immunization Status at the Time of Pediatric Liver Transplant: A 1-year Study through The Society of Pediatric Liver Transplantation

    A. G. Feldman1, A. Kempe2, B. L. Beaty3, R. Torres1, D. Curtis4, S. S. Sundaram1

  • Immunobiogram, a New IVD Immunoassay to Test the Sensitivity Profile of Kidney Transplant Recipients to Immunosuppressive Drugs: Further Results from BH-Pilot Study

    C. Jimenez1, J. M. Portoles2, D. Blánquez3, L. Arribas3, A. Ortega4, T. Diez5, I. Portero6

  • Immunologic Impact Of Native Kidney Function On Liver Transplant Patients

    M. Mujtaba, S. Merwat, J. Fair, M. Bilal, A. Chatila, R. Kulkarni, J. Zou, S. Hussain, A. Gamilla-Crudo

  • Immunologic Outcomes In Recipients Of Orthotopic Liver Transplant Induced Only With Steroids

    S. N. Merwat, A. T. Chatila, M. Bilal, R. Kulkarni, H. L. Stevenson, J. H. Fair, S. K. Merwat, T. Kozlowski, M. A. Mujtaba

  • Immunologically Tolerant Liver Transplant Recipients Are Characterized by Donor-Specific Hypo Responsiveness of Circulating T-cells

    A. A. Duizendstra1, R. J. Knegt de1, M. G. Betjes2, M. P. Peppelenbosch1, N. H. Litjens2, J. Kwekkeboom1

  • Immunomics of Renal Allograft Acute T-Cell Mediated Rejection Biopsies of Tacrolimus- and Belatacept- Treated Patients

    M. van der Zwan1, C. C. Baan1, R. C. Colvin2, R. N. Smith2, R. A. White2, D. N. Ndishabandi2, A. L. Nigg1, T. P. van den Bosch1, G. N. de Graav1, M. C. Clahsen-van Groningen1, D. A. Hesselink1

  • Immunosuppressant Adherence in Adult Heart Transplant Recipients: An Analysis of Pharmacy Claims and Organ Procurement and Transplantation Network Data

    W. S. Cherikh1, A. R. Wilk1, J. Maghirang1, E. A. Witt2, H. Kirkham3, S. Boghani2, N. Hira4, G. Pietradoni2, D. K. Klassen1

  • Immunosuppressant Adherence in Adult Liver Transplant Recipients in the United States

    W. S. Cherikh1, A. R. Wilk1, J. Maghirang1, E. A. Witt2, H. Kirkham2, S. Boghani2, N. Hira3, G. Pietradoni2, D. K. Klassen1

  • Immunosuppression after Organ Transplantation Does Not Enhance Patency of Cold-Stored Vein Allografts for Critical Limb Ischemia -Single Centre Experience

    J. Chlupac, T. Marada, R. Novotny, K. Lipar, L. Janousek, J. Fronek

  • Immunosuppression Increases Regenerative Potential of Adult Rat Cardiac Progenitor Cells in Allogeneic Rat Myocardial Infarction Model

    M. Gunasekaran, R. Mishra, S. Sharma, P. Saha, M. Y. Arfat, C. Ambastha, D. Morales, F. Xuebin, G. J. Bittle, D. Li, S. Kaushal

  • Immunosuppression Reduction after Diagnosis of Sustained BK Viremia and the Risk of Allograft Rejection, Allograft Loss and Mortality

    F. A. Al Dhufairi1, M. Shokoohi2, A. M. Jevnikar1, A. A. House1, D. Kumar3, S. M. Hosseini-Moghaddam1

  • Impact of a Liver Waitlist Candidate LDLT Educational Outreach Program on Referrals and Outcomes of Donor Evaluation

    C. Saroli Palumbo, J. Batisti, R. Batra, J. Dopico, D. Haakinson, L. Hughes, M. Joyce, S. Klein, S. Kulkarni, D. Mulligan, P. Narayanan, M. Schilsky, R. Tomlin, K. Ventura, S. Emre, A. Liapakis

  • Impact of a Novel Digital Medicine Program on Adherence and Utilization in Pediatric Transplant Patients

    S. Sullivan1, K. N. Triplett1, C. Sacks2, M. Tran2, D. M. Desai3

  • Impact of a Short Duration, Narrow Spectrum Perioperative Antibiotic Prophylaxis Regimen on Multi-Drug Resistant Surgical Site Infections in Adult Orthotopic Liver Transplantation

    M. John1, K. Maguigan1, D. Schain2, E. Thomas3, P. Efron4, J. Nelson5

  • Impact of Acute Kidney Injury in Elderly Deceased Donor on the Post-Transplant Clinical Outcomes

    J. Kim1, J. Lee2, Y. Kim3, K. Jin4, S. Han4, Y. Hong1, Y. Chang1, S. Kim1, H. Yoon5, C. Yang2, W. Park4, B. Chung2

  • Impact Of Aggressive Utilization Of Liver Allografts On Outcomes

    A. Rana, M. Kueht, N. Galvan, R. Cotton, C. O'Mahony, J. Goss

  • Impact of an Intra-Abdominal Cooling Device during Open Kidney Transplantation in Pigs

    A. Longchamp1, R. P. Meier2, N. Colucci3, A. Balaphas3, L. Orci3, A. Nastasi3, G. Longchamp1, S. Moll4, A. Klauser5, F. Lazeyras5, M. Pascual6, J. Corpataux7, L. Bühler8

  • Impact of an mHealth, Electronic Pillbox Intervention on Tacrolimus Variability in Kidney Transplantation: Results of a Prospective Randomized Clinical Trial

    J. W. McGillicuddy, L. Sox, J. Chandler, F. Treiber, D. Taber

  • Impact of Belatacept Conversion on Renal Function, Histology and Gene Expression in Kidney Transplant Patients with Chronic Active Antibody-Mediated Rejection

    D. Kumar1, M. Raynaud2, P. Halloran3, A. Loupy2, J. Chang3, J. Reeve3, I. Yakubu1, S. Bobba1, L. Kamal1, M. Levy1, C. Bhati1, P. Kimball1, A. King1, G. Gupta1

  • Impact of Belatacept Conversion on Renal Function, Histology and Gene Expression in Kidney Transplant Patients with Interstitial Fibrosis and Tubular Atrophy

    G. Gupta1, D. Kumar1, M. Raynaud2, A. Loupy2, J. Chang3, J. Reeve3, P. Sanghi1, I. Yakubu1, L. Kamal1, M. Levy1, C. Bhati1, P. Kimball1, A. King1, H. Massey1, P. Halloran3

  • Impact of Case Scheduling on Hospital Cost and Length of Stay in Living Donor Kidney Recipients

    J. Yu1, L. A. Dageforde2, M. B. Doyle1, A. S. Khan1, W. C. Chapman1, Y. Lin1, S. Shenoy1, T. Alhamad3, T. A. Horwedel4, J. R. Wellen1

  • Impact of Clinical Trial Enrollment on Renal Transplant Outcomes

    T. Shertel, A. Eisenhart

  • Impact Of Cold And Warm Ischemia Time On Outcomes For Kidneys Donated After Cardiac Death

    C. Brennan1, P. R. Sandoval2, S. A. Husain2, D. Tsapepas1, S. Mohan2, L. E. Ratner2

  • Impact of Cold Ischemia Time on DCD Kidney Transplant Outcomes

    J. Narvaez, L. Kayler

  • Impact of Coronary Artery Disease on Long-Term Mortality after Liver Transplantation

    S. S. Patel1, V. A. Rodriguez2, M. B. Siddiqui1, J. Laurenzano3, F. Lin3, J. Clinton3, M. Faridnia4, A. Chandrakumaran4, T. Reichman5, C. Bhati5, M. S. Siddiqui1

  • Impact of Cytomegalovirus on the Immune System of Healthy Humans

    W. Zhang, J. Robertson, G. Karadkhele, B. Johnson, C. Larsen

  • Impact of DAA Treatment on Graft Fibrosis in HCV Positive Liver Transplantation

    J. Wellington1, A. Ma2, S. Kottilil3, J. Husson3, E. Wilson3, D. Bruno4

  • Impact of Delayed Graft Function on Allograft Survival in DCD versus DBD Kidneys

    T. Ishaque, A. B. Massie, J. Ruck, C. Holscher, J. G. Wang, D. L. Segev

  • Impact Of Delayed Kidney Transplantation On Positive Crossmatch Liver Kidney Transplantation

    Z. Rokop, C. Kubal, B. Ekser, R. Mangus, J. Fridell, P. Mihaylov, W. Goggins

  • Impact of Discards for Living Donor Kidney Transplantation in Center Transplant Program

    H. Villafuerte1, E. De Sousa-Amorim2, L. Peri3, M. Musquera3, E. Palou4, M. Lozano5, J. Cid5, J. Martorell4, J. M. Campistol2, F. Oppenheimer2, F. Diekmann2, I. Revuelta2

  • Impact of Donor Abdominal Aortic Calcification on Bile Duct Complications of Recipients after Living Donor Liver Transplantation; a Retrospective Study

    Y. Imaoka, M. Ohira, K. Sato, H. Tahara, K. Ide, Y. Tanaka, H. Ohdan

  • Impact of Donor Acute Kidney Injury on GFR at 1 Year

    R. Heilman, A. Kumar, A. Srinivasan, M. Smith, J. Huskey, H. Khamash, A. Mathur, C. Jadlowiec, A. Moss, K. S. Reddy

  • Impact of Donor Acute Kidney Injury on the Outcome of Graft Delayed Graft Function

    C. Jadlowiec, A. Kumar, A. Srinivasan, A. Mathur, M. Smith, J. Huskey, A. Moss, H. Khamash, R. L. Heilman, K. S. Reddy

  • Impact Of Donor And Recipient Race On Kidney Transplant Survivals Evaluated By The Physiochemically-calculated Hla Immunogenicity

    S. Stepkowski, B. Mierzejewska, M. Rees

  • Impact of Donor Hepatitis C Virus Infection on Kidney Transplant Outcomes in the Direct Acting Antiretroviral Era: Time to Revise the KDPI?

    R. M. Cannon, E. G. Davis, L. Mackelaite, H. Dave, M. Eng, C. M. Jones

  • Impact of Early Borderline Histological Changes on Subsequent Events in Renal Transplant Recipients

    R. Mehta, S. Tandukar, D. Jorgensen, I. Owoyemi, N. Shah, C. Puttarajappa, C. Wu, S. Hariharan

  • Impact of Enteric Vancomycin Resistant Enterococcus Colonization on Waitlist Outcomes among Liver Transplant Candidates

    E. Aldag, R. Pedersen, V. Gunabushanam, A. Sahajpal, T. J. Dilworth

  • Impact of Everolimus on Secondary Nonmelanoma Skin Cancer Prevention in Solid Organ Transplant Recipients

    B. Clark1, D. D. Ramirez1, A. Carlson1, B. Sirandas1, C. Truax1, L. Smith1, I. Hall2

  • Impact of Everolimus Therapy on HIV Persistence and Gene Expression in Transplant Patients

    A. Zarinsefat1, C. Schreiner1, C. Cameron2, S. Chu1, M. P. Busch1, T. Liegler1, S. G. Deeks1, T. J. Henrich1, P. G. Stock1

  • Impact of Extremely Prolonged Cold Ischemia Time in Combination with AKI on Kidney Transplantation Outcome – A Single Center Experience

    N. Sharma, Z. Haddad, Y. Qazi

  • Impact of Functional Delayed Graft Function in the Modern Era of Kidney Transplantation

    D. Cucchiari, A. Molina-Andujar, E. Montagud-Marrahi, J. Rovira, F. Diekmann

  • Impact of Glomerulitis at 4-Month Biopsy on Long Term Kidney Allograft Outcomes

    M. Whigham, G. Mour, M. Buras, S. Sukumaran Nair, A. Jaramillo, D. Ramon, R. Heilman

  • Impact of Glycemic Control on Long Term Graft and Patient Outcomes after Pancreas Transplantation

    V. S. Rohan1, K. Soliman1, V. Kalbhavi2, S. N. Nadig1, A. Lin1, V. Rao1, D. Taber1

  • Impact of Granulocyte Colony Stimulating Factor on Clinical Outcomes in Kidney Transplant Recipients with Neutropenia

    H. Yao1, A. Alam2, R. Sapir-Pichhadze2, D. D’Arienzo3, D. Baran2, S. Sandal2, M. Cantarovich2

  • Impact of Hepatitis C Viremia on Post-Transplant Diabetes Mellitus Development in Liver Transplant Recipients

    K. Klein1, J. Nelson2, B. Crowther1, C. Guerra3, E. Kincaide1, K. V. Speeg4, N. Alkhouri5, R. Hall1

  • Impact of HLA Mismatches and Cytomegalovirus Seropositivity on Outcomes Following Heart Transplantation

    A. Singhvi, R. Araujo-Gutierrez, M. H. Park, A. Bhimaraj, B. H. Trachtenberg, I. Hussain, A. Guha

  • Impact of HLA-DR Matching on HLA-DQ Matching Status and the Development of Anti-HLA-DQ De Novo DSA under Calcineurin Inhibitor or Belatacept Immunosuppression

    V. Jucaud1, H. Gebel2, R. Bray2, M. Polinsky3, M. Everly1

  • Impact of IgG Subclass and C1q Binding Donor-Specific HLA Antibodies on Antibody Mediated Rejection in Kidney Transplant Recipients

    H. Lee1, J. Ryu1, S. Yun1, T. Ban2, E. Ko2, C. Yang2, E. Oh1

  • Impact of Immunosuppressive Drug Withdrawal on Persistent Mixed Chimerism in Recipients of HLA Haplo-Identical Kidney and Hematopoietic Cell Transplants

    S. Busque, J. Scandling, R. Lowsky, J. Shizuru, E. Meyer, K. Jensen, A. Shori, R. Hoppe, E. Engleman, S. Strober

  • Impact of Induction Choice and Early Steroid Withdrawal on Outcomes in HLA Zero Mismatched Kidney Transplant Recipients

    C. Votruba1, K. Holdener1, B. Astor2, F. Aziz2, D. Mandelbrot2

  • Impact Of Inhaled Vasodilator Therapy On Early Morbidity And Mortality After Lung Transplant

    M. Tomeczkowicz1, A. Wexler1, M. Patel2, J. Fernandez-Castillo2, J. Rusniak1, E. Mancl3, S. Quddus2

  • Impact of Liver Recipient Genotype on Tacrolimus

    S. Tremblay1, T. Fukuda2, T. Mizuno2, A. A. Vinks2, E. Woodle1, J. Klawitter3, J. Klawitter3, U. Christians3, R. R. Alloway1

  • Impact of MELD-Na Course (Delta MELD-Na) on Outcome after Liver Transplantation

    G. Silberhumer1, G. Gyoeri1, L. Unger2, G. Harpain1

  • Impact of Multidrug-Resistant Microbes of Donor Lower Respiratory Tract on Early Posttransplant Pneumonia in Bilateral Lung Transplant Recipients without Pretransplant Infection

    S. HAN1, S. Kim2, M. Park3, J. Lee4, H. Paik4

  • Impact of Multidrug-Resistant Organisms among Donors on Organ Utilization

    J. A. Anesi1, E. Lautenbach1, J. H. Han1, D. H. Lee2, H. Clauss3, A. Climaco4, R. Hasz5, E. Molnar3, D. Alimenti1, S. West5, W. B. Bilker1, P. Tolomeo1, E. A. Blumberg1

  • Impact of Once-Daily Tacrolimus on Trough Concentration Variability in Stable Adolescent and Young Adult Renal Transplant Recipients

    M. Moss, J. Goebel, A. Lofton, E. Steinberg, M. Bock

  • Impact of Pre-Kidney Transplant Cinacalcet Use on Post-Transplant Outcomes

    L. Bowman1, S. Lloyd2, J. Buggs1, H. Pearson1, R. Baliga3, E. Rogers1, A. Kumar4

  • Impact of Preoperative Rifaximin Use on Reducing Graft Injury in Liver Transplantation: A Propensity Matched Analysis

    T. Ito, K. Nakamura, S. Kageyama, H. Hirao, K. Kadono, J. Aziz, J. DiNorcia, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, J. Kupiec-Weglinski, F. M. Kaldas

  • Impact of Previous Hepatic Resection on the Outcome of Liver Transplantation: A Case-Control Analysis

    M. Serenari, M. Paterno, A. D. Pinna, M. Ravaioli, E. Prosperi, M. Del Gaudio, C. Zanfi, V. Bertuzzo, G. Frascaroli, M. Cescon

  • Impact of Prolonged Venous Thromboembolism Prophylaxis on 30-Day Hemostatic Outcomes Following Kidney Transplantation in Patients with Hypercoagulable Risk Factors

    V. Behbahani, A. Santeusanio, S. Ames, R. Shapiro

  • Impact of Protease Inhibitor-Based Anti-Retroviral Therapy on Tacrolimus Intrapatient Variability in HIV+ Kidney Transplant Recipients

    M. H. Cooper, I. E. Dunne, S. A. Kuten, A. E. Cantwell, E. A. Graviss, D. T. Nguyen, M. J. Hobeika, A. O. Gaber

  • Impact of Race and Substance Use on Listing Decisions for Kidney Transplant

    R. N. DeBlasio1, L. Myaskovsky2, K. Kendall1, A. DiMartini1, G. Switzer1, D. M. Posluszny1, C. Puttarajappa1, A. D. Tevar1, S. Hariharan1, R. Shapiro3, M. A. Dew1

  • Impact of Recipient Age in Combined Liver-Kidney Transplantation (CLKT): Caution is Needed for Elderly Patients≥70 Years

    B. Ekser1, W. C. Goggins1, R. S. Mangus1, P. Mihaylov1, J. A. Fridell1, M. A. Lacerda2, M. S. Ghabril2, J. A. Powelson1, C. A. Kubal1

  • Impact of Revised Policy for Hepatocellular Carcinoma MELD Exception Points on Recurrence after Liver Transplantation

    P. Le1, L. McClelland1, K. Knapp1, T. Xu1, S. Pelletier2

  • Impact Of Rituximab And Maintenance Steroid In The Recurrence Of Focal Segmental Glomerulosclerosis

    L. A. Mendez Castaner

  • Impact Of Selective Cd28 Blockade On Protective Immunity To A Murine Epstein-Barr Virus Homolog

    R. L. Crepeau, J. A. Elengickal, M. L. Ford

  • Impact of Simultaneous Pancreas-Kidney Transplantation on Cardiovascular Risk in Type 1 Diabetic Patients

    E. Montagud-Marrahi

  • Impact of Six-Month Surveillance Biopsies and Monitoring on 2-Year Outcomes in Pediatric Renal Transplant Recipients

    J. Lyons1, D. Ranch2, R. Hall1, P. Maxwell1, K. Hitchman2, B. Crowther1

  • Impact of Size Mismatch on Long-Term Graft Survival after Orthotopic Liver Transplantation

    K. Kamrani1, A. Okoh2, A. Mathur3, L. Brown4

  • Impact of Steroid-Free Protocol on Incidence of Posttransplantation Diabetes Mellitus: A Prospective, Randomized, Multicenter, Open-Label, Controlled Trial in Renal Transplant Recipients

    J. Ekberg1, S. Baid-Agrawal1, B. Jespersen2, R. Källén3, E. Rafael3, K. Skov2, P. Lindnér1

  • Impact Of Subclinical Bk Virus-associated Nephropathy In High-risk Recipients

    M. E. Seifert, E. P. Kasik, M. Bernard, G. Agarwal, H. Fatima, R. Gaston, B. Julian, C. Kew, V. Kumar, S. Mehta, S. Ong, F. Rosenblum, G. Towns, R. B. Mannon

  • Impact of T-cell Mediated Allograft Inflammation within First-Year after Kidney Transplantation: An Analysis of Paired Biopsies from a Single Center Study

    S. Tandukar, R. Mehta, I. Owoyemi, D. Jorgensen, P. Sood, S. Hariharan

  • Impact of T-cell Mediated Allograft Rejection and Antibody Mediated Rejection within the First Year after Kidney Transplantation

    I. Owoyemi, D. Jorgensen, S. Tandukar, R. Mehta, S. Hariharan

  • Impact of Tacrolimus Formulation on Tacrolimus Level Coefficient of Variations

    S. January1, T. Horwedel2, J. Hagopian1, C. Carthon1, A. Gharabagi3, R. Delos Santos4

  • Impact of the 2013 Change in Definition of Increased Risk Donors on Lung Transplant Outcomes

    C. J. Lehr1, R. Lopez2, S. Arrigain2, J. D. Schold2, M. Valapour1

  • Impact of the Organ Procurement Organization Surgeon on Utilization of High KDPI Kidneys

    C. S. Hwang1, J. Reese2, T. Anthony2, P. Vagefi1, B. Tanriover3, V. Ariyamuthu3, S. Levea3, M. MacConmara1

  • Impact of the Pediatric End-Stage Liver Disease Growth Failure Threshold on Waitlist Mortality in Children Awaiting Liver Transplant

    S. M. Swenson, J. P. Roberts, S. Rhee, E. R. Perito

  • Impact Of The Provision Of Transplant Information On Access To First And Repeat Kidney Transplantation

    S. Clark, A. Abdalla, M. Kadatz, J. Gill, J. S. Gill

  • Impact of Time-of-Day of Declamping on Kidney Transplant Outcome

    D. Montaigne1, N. Al Hawajri2, M. Jacquelinet1, A. Coppin1, M. Frimat3, S. Bouyé3, G. Lebuffe3, F. Bayer2, M. Lassalle2, B. Staels1, M. Hazzan3, C. Jacquelinet4

  • Impact Of Transplant Center And Regional Characteristics On Racial Disparities On Readmission After Kidney Transplantation

    J. Hogan1, K. Li1, R. Zhang1, J. Sun2, A. B. Adams1, R. E. Patzer1

  • Impact of Transplant Surgery Advanced Practice Providers in the Management of Pancreas Transplant Recipients

    E. A. Herriman, J. M. Sharp, K. J. Brown, J. R. Montgomery, J. C. Magee, J. D. Punch, R. S. Sung, K. J. Woodside

  • Impact of Transplant Ureteral Stricture Location and Type of Ureteral Revision on Long-Term Graft Survival and Patient Outcomes in Kidney Transplantation

    C. Shepherd1, R. Cameron2, C. Holbrooks2, A. Lin3, S. Nadig3, J. McGillicuddy3, D. Dubay3, D. Taber3, P. Baliga3, V. Rohan3

  • Impact of Ureteral Stent on Urinary Tract Complications after Deceased Donor Renal Transplantation

    L. Zheng, H. Jia, H. Chen, J. Wu

  • Impact of Vancomycin-Resistant Enterococci Gut Colonization on Liver Transplant Outcomes

    D. Chiang, T. C. Dingle, S. Belga, D. Kabbani, J. Walter, J. G. Abraldes, C. Cervera

  • Impacts of Mycophenolate Mofetile Addition to Very Low Exposure Everolimus and Calcineurine Inhibitor Based Immunosuppression in De Novo Kidney Transplantation 5 Years Results

    Y. Watarai1, S. Narumi1, T. Tomosugi1, M. Okada1, K. Futamura2, M. Tsujita2, T. Hiramitsu1, T. Kobayashi3, N. Goto2

  • Implementation of a De Novo Belatacept Protocol

    D. Wojciechowski1, M. Jacobs2, K. Safa1, H. Gilligan1, H. Eliot1, W. W. Williams, Jr1

  • Implementation of a Longitudinal Comprehensive Multidisciplinary Transition Program and Seminar – Safely Making the Long Leap to the Adult World

    M. Moss, E. Steinberg, A. Sikora, K. McKinnon, J. Goebel, M. Bock

  • Implementation of Novel Machine-Learning Techniques to Tailor Donornet® Organ Offers to Center and Surgeon Preference

    A. C. Perez-Ortiz, N. Elias

  • Implication of Melanocortin Receptors in Alloimmunity

    M. Uehara, B. S. Al Dulaijan, J. Azzi, R. Abdi

  • Improved Transplant Outcomes in Ischemia-Free Liver Transplantation: A Report of the First 30 Cases

    X. He, Z. Guo, W. Ju, Q. Zhao, S. Huang, J. Yang, L. Wang, Y. Tang, Z. Zhang, Z. Zhu, L. Yang, Y. Zhu, F. Gong, C. Cai, W. Huang, G. Chen, M. Chen, F. Ji, M. Han, A. Hu, L. Wu, Y. Ma, D. Wang, J. Huang, X. Li

  • Improvement of the Outcome of Clinical Islet Transplantation Depending on the Era in Japan

    Y. Akashi1, T. Kenmochi2, T. Ito3, K. Kurihara2, N. Aida2, A. Kawai2, M. Hayashi4, K. Kouketsu4

  • Improving Access to Lung Transplant through Donor Strategy: A Decision Analysis

    W. Tsuang, B. Udeh

  • Improving Living Donor Follow Up

    L. Aronoff, V. Nair, C. Flores, M. Bhaskaran, E. Molmenti, A. Fahmy, M. Zhou, E. Grodstein, D. Campbell, C. Literello, L. Teperman

  • Improving Medication Adherence and Outcomes in Adult Kidney Transplant Patients Using SystemCHANGETM: Results of the Medication Adherence Given Individual Change (MAGIC) Randomized Clinical Trial

    M. R. Wakefield1, C. M. Ashbaugh2, L. Remy3, D. Aholt3, C. Miller3, S. Ye3, D. K. Hathaway4, D. Clark4, V. S. Staggs5, K. Goggin6, R. J. Ellis7, C. L. Russell3

  • Improving Pre-Kidney Transplantion Laboratory Utilization in an Era of Increasing Waitlist Size

    G. K. Mahowald1, B. Kimball2, N. Elias2, E. Heher3, T. Girouard1, S. L. Saidman1, V. Pattanayak1

  • Improving the Organ Donation Process: Updated

    J. Yeh, M. P. Jarrett, L. Teperman

  • In Depth Look at Acute Rejections in LCP-Tacrolimus (LCPT; Envarsus XR) and Immediate-Release Tacrolimus (IR-Tac)-Treated De Novo Kidney Transplant Recipients

    A. Condon1, M. Mujtaba2, S. J. Patel3, D. R. Stevens3, U. Meier-Kriesche3

  • In Vitro Model for Detection of HLA Antibodies from Long Lived Plasma Cells

    M. Merzkani1, N. Moore1, X. Benavides1, B. Smith1, W. Park1, A. Bentall1, K. Medina2, M. Gandhi3, M. Stegall1

  • In Vitro Model to Study the Effect of Irradiation Preconditioning on Alloimmune Responses: Development of Potential Predictive Markers

    K. Shimozawa, K. Janec, L. Contreras-Ruiz, E. C. Guinan

  • In Vivo Treg Expansion under Costimulation Blockade Targets Early Rejection and Improves Long-Term Outcome

    C. Schwarz1, B. Mahr2, L. Unger1, N. Pilat2, H. Regele3, T. Wekerle2

  • In Vivo/In Situ Behaviour of Allogeneic Spleen versus Bone Marrow Cells in Wild-Type Neonatal Mice: Insights into Robust Transplant Tolerance Induction

    R. A. Bascom, K. Tao, L. J. West

  • Inadequate (ax) Transbronchial Biopsies Are Not Associated With Clad Or Death After Lung Transplantation

    L. Levy1, E. Huszti2, J. Tikkanen3, R. Ghany3, S. Keshavjee3, T. Martinu3

  • Incidence and Mortality of Renal Cell Carcinoma after Kidney Transplantation: A Meta-Analysis

    A. Chewcharat1, C. Thongprayoon2, B. Boonpheng3, A. Torres-Ortiz4, M. A Mao2, N. J Khoury5, W. Cheungpasitporn4

  • Incidence and Predictors of Post-Kidney Biopsy (KBx) Bleeding in Liver Transplant (LT) Candidates with Renal Dysfunction

    H. M. Wadei1, P. Abader1, N. Aslam2, T. Jarmi1, A. P. Keaveny1, K. Croome1, D. D. Lee1, C. Taner1

  • Incidence and Risk of Allograft Rejection after Cardiac Transplantation in Left Ventricular Assist Device Patients

    R. C. Patel1, L. B. Cooper2, S. D. Barnett2, R. T. Cole2, M. A. Psotka2, A. Cochrane2, S. Sinha2, L. J. Bogar2, S. S. Desai2, P. Shah2

  • Incidence and Risks for Non-alcoholic Fatty Liver Disease and Steatohepatitis Post Liver Transplant: Systematic Reveiw and Meta-Analysis

    N. Saeed1, P. Sharma2, L. Glass2, C. Shannon2, C. Sonnenday2, M. Konerman2

  • Incidence of Autoresuscitation in Donation after Cardiac Death Donors

    C. W. Koo1, R. A. Helmick1, K. Van Frank2, K. Gilley2, J. D. Eason1

  • Incidence of Cytomegalovirus in Moderate Risk Kidney Transplant Recipients Receiving Low Dose Valganciclovir

    T. Fallah1, A. Logan2, L. Beltran Garcia3, L. Bowman2

  • Incidence of De Novo Donor Specific Antibodies and Treatment Response for AMR in Pediatric Kidney Transplant Recipients

    S. Gattis1, R. Liverman1, A. Serluco1, J. Yin1, H. C. Sullivan2, R. A. Bray3, H. M. Gebel3, S. Jernigan4, R. George4, P. D. Winterberg4, R. Garro4

  • Incidence of Viral Infections in Kidney Transplant Recipients with Alemtuzumab or Rabbit Antithymocyte Globulin Induction

    A. Brueckner1, C. Truong1, E. Yanqui1, R. Baliga2, L. Bowman1

  • Incidence, Risk Factors, Outcomes and Clinical Management of BK Viremia in the Modern Era of Kidney Transplantation

    J. Kim

  • Incisional Hernia Repair Post Liver and or Kidney Transplantation

    J. Buggs1, A. Brando2, J. Sokolich1, E. Rogers1, A. Kumar3, V. Bowers1

  • Incisional Ventral Hernia Repair (IVHR) in Post Liver Transplant Recipients (OLT) through a Robotic-Assisted Intervention (RAI): Initial Single-Center Experience

    A. Mejia, C. G. Fasola, A. Stegall

  • Inclusion of Compatible Pairs in the Australian Paired Kidney Exchange Program

    E. van Hardeveld1, S. McGinn2, L. Cantwell3, M. Kummrow3, P. Hughes1

  • Incorporating Tangible Benefits into the Risk-Benefit Analysis of Living Organ Donation Decisions

    M. Robin1, S. Rasmussen2, A. Saha2, A. Eno2, M. Waldram2, D. Segev2, M. Henderson2

  • Increase in 48 Month Cumulative Acute Rejection Rates in the Most Recent Cohort: The 2018 Transplant Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS)

    V. Dharnidharka1, C. Cramer2, A. Chua3, A. Moudgil4, K. Martz5, T. Blydt-Hansen6, J. Smith7, A. Neu, on Behalf of The NAPRTCS Investigators8

  • Increase in Deceased Donor Acceptance Rate After Implementing Uniform Acceptance Criteria

    C. Klein, T. Ommert, J. Hundley, J. Lizcano, A. Ray, R. Cross, K. Payne

  • Increase in Proinflammatory CD14++CD16+ Monocytes in Samples from Aspiration Cytology Compared with Peripheral Blood in Kidney Transplant Patients with Borderline Rejection

    T. Vazquez-Sanchez1, A. Caballero-Gonzalez2, E. Sola1, P. Ruiz-Esteban1, E. Marques1, J. Alonso-Titos1, E. Palma1, C. Jironda1, M. Cabello1, V. Lopez1, P. Hidalgo1, M. Leon1, D. Hernandez1

  • Increased Access to Transplantation for Medicaid Patients Following Medicaid Expansion

    A. Massie, M. Henderson, T. Hwee, D. Segev

  • Increased Frequency of Myeloid-Derived Suppressor Cells Contributing to Prolong Skin Allograft Survival in Aged Mice

    W. Lee, Y. Wang, T. Wu, C. Cheng, C. Lee, T. Wu, H. Chou, K. Chan

  • Increased Number of Intragraft FoxP3+ T Cells is Strongly Correlated with Decreased Graft Survival in Chronic Active Antibody Mediated Rejection

    K. Sablik1, K. Jordanova2, M. Clahsen-van Groningen1, M. Betjes1

  • Increased Ratio of Circulating Tfh for Tfr Cells in Chronic Renal Allograft Dysfunction: A Pilot Study

    L. Yan, Y. Li, Y. Li, X. Wu, X. Wang, L. Wang, Y. Shi, J. Tang

  • Increasing Doses of Pain Medications Pre-Heart Transplant as a Risk Factor for Outcomes after Transplant

    K. Shah, D. H. Chang, J. Patel, R. J. Levine, S. Dimbil, E. Passano, J. A. Kobashigawa

  • Increasing Expression of B-cell Maturation Antigen during the Development of Recall Antibody Responses: A Prospective Pharmaceutical Target for B-cell Suppression?

    G. Wu, I. Kim, N. Chai, A. Klein, S. Jordan

  • Increasing Incidence and Transplantation of Individuals Listed with Alcoholic Liver Disease

    E. L. Godfrey1, A. Rana2, J. A. Goss2

  • Increasing Net Immunosuppression after BK Viremia

    L. Cotiguala, A. Masood, J. Park, A. Naik

  • Increasing the Number of Liver Transplants through Active Review of Offers Turned Down

    M. L. Melcher, C. A. Bonham, A. Gallo, W. Concepcion, I. Jacobson, C. O. Esquivel

  • Increasing Time-in-Therapeutic Range of Tacrolimus is Associated with Superior Outcomes in Living Kidney Transplants

    T. Lin, T. Song, S. Yin, Y. Jiang, Z. Huang, X. Wang, J. Liu, Z. Wang

  • Independent Risk Factors for Discard of Pediatric Liver Allografts

    T. H. Malik1, J. Goss2, N. T. Galvan2, M. L. Kueht II2, A. Rana3

  • Indicators of Impending Pig Organ Xenograft Failure: Relevance to Clinical Xenotransplantation

    H. Iwase1, A. Jagdale1, T. Yamamoto1, G. Zhang1, Q. Li1, J. Foote1, D. Ayares2, H. Hara1, D. K. Cooper1

  • Individualized Preconditioning for ABO-Incompatible Living Donor Kidney Transplantation: An Initial Report of 48 Cases from China

    X. -. Wang

  • Indocyanine Green Fluorescence Imaging during Normothermic Ex Vivo Liver Perfusion for the Assessment of Hepatocyte, Biliary, and Vascular Function

    T. Goto, I. Linares, S. Ganesh, L. Mazilescu, P. Urbanellis, N. Selzner, M. Selzner

  • Induction Immunosuppression Practices in Liver Transplantation are Variable and Predict Post-Transplant Survival

    T. Bittermann1, R. Hubbard2, J. Lewis1, D. Goldberg1

  • Induction Therapy in Elderly Kidney Transplant Recipients with Low Immunological Risk

    C. Masset1, J. Boucquemont2, V. Garrigue3, M. Ladrière4, F. Buron5, E. Cassuto6, Y. Foucher2, J. Dantal1

  • Induction Therapy Modulated by the Absence of Preformed Donor-Specific Antibodies (DSAS) Regardless of the Level of Sensitization

    M. Cristelli, K. Linhares, R. de Marco, L. Viana, C. Felipe, M. Gaspar, C. Peixoto, G. Marcelo Gomes, J. Toniato Rezende, K. Nunes Ficher, L. Alfaro Villanueva, V. Lima, M. Gerbase de Lima, J. Medina Pestana, H. Tedesco Silva Junior

  • Induction Type Does Not Influence Kidney Graft or Patient Survival in Recipients with a Previous Heart Transplant in the United States

    S. M. Riad1, A. Tamas1, S. Jackson2, C. Martin1

  • Induction Type Does Not Influence Kidney Graft or Patient Survival in Recipients with a Previous Lung Transplant in the United States

    S. Riad1, U. Goswami2, S. Jackson3, M. Hertz2

  • Induction with Thymoglobulin in DCD Kidneys. Dose Effect and Predictors of Outcome

    A. Asderakis, T. Sabah, A. Jones, E. Ablorsu, L. Szabó, R. Chavez

  • Infectious Complications after Treatment of Antibody-Mediated Kidney Allograft Rejection: A National Cohort Study

    N. Perrottet1, D. Golshayan2, O. Manuel2, V. Aubert2, M. Koller3, K. Hadaya4, L. Bühler4, T. Mueller5, U. Huynh-Do6, S. Dahdal6, I. Binet7, M. Dickenmann3, S. Schaub3, J. Steiger3, M. Pascual2, M. Fernández-Ruiz2

  • Infectious Complications in 71 Heart Transplant Recipients at King Chulalongkorn Memorial Hospital, Thailand

    N. Sangpornsuk1, J. Wanichwatphibun2, A. Ariyachaipanich3, P. Ongcharit4, K. Jutivorakool5, J. Vanichanan5

  • Infectious Complications in Kidney Transplant Recipients Age 65 and Older

    L. E. Liriano-Ward1, M. Barbachan e Silva2, Y. Azzi1, M. Ajaimy1, A. Cambell1, J. Graham1, J. Rocca1, C. Pynadath1, G. Nair1, O. Andacoglu1, S. Greenstein1, P. Ó Broin2, E. Akalin1

  • Infectious Complications in Tocilizumab-Treated Kidney Transplant Recipients

    S. Sethi, A. Peng, R. Najjar, A. Vo, S. Jordan, E. Huang

  • Infectious Complications of Eculizumab Use in Abdominal Organ Transplant Recipients

    A. M. Nolan1, E. J. Fraser2, H. K. Grewal3, J. G. Timpone3

  • Infectious Risk of Rejection Therapy Following Heart Transplantation; Can It Be Avoided?

    M. Kittleson, J. Patel, S. Dimbil, R. J. Levine, G. Esmailian, A. Shen, T. Hage, J. A. Kobashigawa

  • Infective Complications after Renal Transplantation – A Single Centre Experience Comparing Alemtuzumab to Basiliximab Induction

    R. Czajka, M. Welberry Smith, M. Gittus, E. Lindley, M. Vernon

  • Inferior Graft and Patient Survival Following Offspring to Parent Living Donor Liver Transplantation

    R. A. Choudhury, A. Dagan, H. Yaffe, D. Yoeli, E. A. Pomfret, T. L. Nydam

  • Inflammation and Fibrosis Are Observed in 34% of Clinically Stable Adult Liver Transplant Recipients

    L. Sun1, J. Levitsky2, S. Feng3, A. Humar4, A. J. Demetris4, J. Emond5, A. Shaked6, G. Klintmalm7, K. Mason8, M. DesMarais1, A. Priore9, N. Bridges9, B. E. Burrell10, S. Chandran3, J. Markmann11

  • Influence Of HLA-DR Mismatches On Long Term Outcomes Following Heart Transplantation

    A. Singhvi, R. Araujo-Gutierrez, M. H. Park, A. Bhimaraj, B. H. Trachtenberg, I. Hussain, A. Guha

  • Inhibition of Autophagy Prolongs Recipients Survival through Accelerating CD8+ T Cell Apoptosis in a Rat Liver Transplantation Model

    X. Chen1, Q. Yang1, X. Li2, Y. Deng1, G. Chen1, G. Wang1

  • Inhibition of CXCR3 Expression through Blockade of STAT3 Alpha Signaling Down-Regulate Inflammation of Renal Ischemia-Reperfusion Injury

    J. Kim1, J. Park2, K. Yoo2, J. Moon1, J. Jeong1, C. Lee3, Y. Kim1, S. Yang4

  • Inhibition of Cyclin-Dependent Kinase 2 Signaling Prevents Liver Ischemia and Reperfusion Injury

    Z. Xue, J. Xu, C. Zhang, Y. Liu, R. Busuttil, J. Kupiec-Weglinski, H. Ji

  • Inhibition of mTORC2 Causes Hyper Phosphorylation of ERK Induced by Co-Ligation of HLA-I and II Antibody

    Y. Jin1, J. Sinnet-Smith2, E. Rozengurt2, E. F. Reed1

  • Inhibition of Sialidase Activity and Galectin Binding Reduces Xenogeneic Neutrophil-Endothelial Adhesion

    B. M. Cerel1, B. M. French2, D. G. Harris2, C. Laird2, L. Burdorf1, X. Cheng2, C. Feng3, A. S. Cross4, S. E. Goldblum4, G. R. Vasta3, R. N. Pierson III1, A. M. Azimzadeh1

  • Inhibition of Th1 and Th17 Cell Differentiation and Prolonged Graft Survival through NFAT Pathway Downregulation

    C. Dai1, R. Tan1, B. Yang1, J. Markmann2, D. Chen1, L. Wei1, Z. Chen1

  • Inhibition of TLR4 Mediated Programmed Necrosis Does Not Improve Graft Function and Histology in a Murine Kidney Transplant Model

    S. Jain1, R. Plenter2, T. Nydam2, A. Jani1

  • Initial Peritoneal sST2 Levels Are Associated with Peritoneal Failure and ST2 Blockade Mitigates TGF-β and High Glucose-Induced Peritoneal Fibrosis

    Y. Kim1, S. Lee1, M. Yu1, H. Lee1, Y. Kim1, C. Lee2, R. Cha3, S. Yang4

  • Initial Single-Center Results from the Pilot Transplant Quality Improvement Project in Liver Transplant

    A. Zarinsefat, S. M. Syed, R. Hirose

  • Innate Immunity in Brain Dead Donors: Implications of Necroptosis in Kidney Allograft Outcomes

    A. Ang1, A. Zmijewska2, T. M. Stevens3, J. Murphy1, R. B. Mannon2

  • Innovations in Transplant Education: 360⁰ Virtual Reality Videos of a Live Kidney Donation and Transplantation

    V. A. Huurman1, A. D. Pieterse2, F. Luk2, M. E. Reinders2

  • Inpatient versus Outpatient Management of Hyperglycemia in Post-Transplant Patients Following High Dose Steroid Pulses for Acute Rejection

    J. L. Wisniewski1, W. Bruneau2, E. A. Cohen2

  • Insertion of Internal Stent in Duct-to-Duct Biliary Reconstruction to Reduce Bile Duct Complication in Living Donor Liver Transplantation

    H. Choi1, G. Na2

  • Insulin Resistance as a Surrogate Marker for Post-Transplantation Diabetes Mellitus

    D. D. de Lucena, É. B. Rangel, J. R. de Sá, J. O. Medina-Pestana

  • Insulin Treatment in Pancreas Donors on the Intensive Care is a Marker of Beta Cell Death as Evidenced by microRNA Data

    I. Shapey, A. Summers, J. O'Sullivan, P. Yiannoullou, N. Hanley, T. Augustine, M. Rutter, D. van Dellen

  • Insurance Status Impacts Treatment for Hepatocellular Carcinoma

    L. Sobotka1, A. Hinton2, L. Conteh1

  • Intact Lymphatics Are Essential for Costimulation Blockade-Induced Lung Allograft Survival

    L. Wang1, H. Reed2, R. Han1, M. Kahn2, W. W. Hancock1

  • Integrated Analysis of Messenger RNA and Micro RNA Profiles in Fatty Liver Donors: Molecular Networks during Ischemia Reperfusion Injury

    D. Maluf1, A. Bajwa1, S. K. Satapathy2, V. Sai Bontha1, A. Kadimella1, J. Eason3, V. Mas4

  • Integration Of Business Intelligence (BI) Solution In Tertiary Renal Transplant Centre To Drive Clinical Decisions.

    M. Heer, S. Yausis, P. R. Trevillian

  • Integrative Analysis of Immune Repertoire and Gene Expression from RNA-seq in Kidney Organ Transplants

    S. Pineda1, A. Ravoor2, O. Bestard3, M. Sarwal1, M. Sirota2

  • Interferon Sensitivity Promotes Recovery from Acetaminophen Induced Liver Injury

    S. Datta, T. Hamilton, G. C. Sen

  • Interleukin-27 is Required for Donor Specific Antibody Production in Response to Heart Allograft Transplantation

    M. Nicosia, S. Miyairi, R. Fan, A. Beavers, V. Gorbacheva, A. Valujskikh

  • International Multicenter Study Evaluating Clinical Outcomes Associated with Acute Antibody-Mediated Rejection

    S. Corman1, I. Hirji2, E. Brouwer2, S. H. Park1, C. Macahilig3, A. Vergani2, T. Bo2, P. Wolthoff3, P. Keown4

  • Interpretable Post-Transplant Graft Failure Prediction Using Decision Tree Neural Networks

    J. N. Valdez1, T. Fu1, J. Hogan2, S. Adhikary1, M. Arenson2, R. Zhang2, X. Zhang3, K. Li2, A. B. Adams2, R. E. Patzer2, J. Sun1

  • Interruption of Notch Signaling via Blockade of Delta-Like Ligands 1 and 4 Prevents Co-Stimulation Blockade Resistant Allograft Rejection

    A. Matar, Y. Dong, B. Lovasik, D. Mathews, A. Ghosh, C. Breeden, A. Stephenson, W. Kitchens, A. Adams

  • Interstitial CD68+ Cells Infiltration and Kidney Graft Outcome

    E. Paoletti1, E. Bussalino2, L. Marsano1, D. Bellino1, R. Russo1, A. Parodi1, G. Garibotto2, J. L. Ravetti3

  • Intra-abdominal Hypertension And Abdominal Compartment Syndrome: An Organ Procurement Organization’S Experience

    J. Stefek1, L. E. Markham1, M. Ott1, S. S. Johnson2, J. C. Olson3, H. Sangha4, D. G. Vasquez5, S. P. Whitt6, H. E. Wilkins1, P. A. Webster1, M. Iliakova7, M. Moncure7

  • Intra-Abdominal Hypertension in Simultaneous Pancreas-Kidney Transplantation

    T. Ameen, G. Papadakis, R. Punjala, N. Karydis

  • Intra-Operative Kinetics of Anti-HLA Antibodies in Simultaneous Liver-Kidney Transplantation

    M. Kueht, P. Jindra, M. Cusick, N. Galvan, A. Rana, J. Goss

  • Intracerebral Hemorrhage in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease: A Nationwide Analysis

    W. Cheungpasitporn1, C. Thongprayoon2, P. Ungprasert3, K. Wijarnpreecha4, F. T. Chebib2, P. T. Kroner4

  • Intraoperative Blood Loss and Transfusion during Pediatric Liver Transplantation: A Single Center Experience

    J. A. Villarreal1, D. Yoeli2, J. Yoeli3, R. Ackah4, R. Sigireddi1, M. Kueht1, N. Galvan1, R. Cotton1, A. Rana1, C. O’Mahony1, J. Goss1

  • Intraoperative Portal Vein Flow Can Predict Early Acute Kidney Injury Following Allogeneic Liver Transplantation: A Retrospective Observational Study

    J. Zhang1, A. Jiao2, Q. Liu1, C. Zhang1, N. Sun1, X. Li1

  • Intravenous Immunoglobulin Significantly Reduces Bioavailability of Concomitantly Administered Anti-C5 Monoclonal Antibodies

    S. C. Jordan1, K. Kucher2, M. Bagger2, H. Hockey3, K. Wagner4, N. Ammerman1, J. Choi1, A. Vo1

  • Intravenous Methamphetamine Does Not Appear To Be A Contraindication For Heart Donation In Heart Transplantation

    A. Velleca, J. Patel, M. Kittleson, R. Levine, S. Dimbil, S. Mersola, M. Hamilton, F. Esmailian, J. A. Kobashigawa

  • Intrinsic Organ Quality Assessment Using Integrative Short Outcome Prediction Composite Scores

    K. Archer1, V. Bontha2, Y. Zhang1, J. Eason3, A. Bajwa2, L. Gallon4, E. Akalin5, D. Maluf2, V. Mas6

  • Introduction of Universal Hepatitis E RNA Screening in Deceased Organ Donors – The UK Experience

    I. Ushiro-Lumb1, K. Tettmar1, I. Johannessen2, K. Simpson2, I. Hart3, J. Timms4, A. Hale5, S. Ijaz6, R. Tedder6, J. Forsythe1

  • Investigating Deceased Donor Kidney Discard Trend – An Opportunity To Expand The Donor Pool

    J. A. Shah1, D. P. Borle1, K. Koontz2, W. Irish1, K. V. Ravindra1

  • Investigation and Regulation of Induced Anti-Pig Antibody Production in GTKO Pig-to-Cynomolgus Monkey Artery Retransplantation

    S. Hurh1, E. Lee1, J. Jeong2, G. Lee1, S. Park1, S. Ahn3, S. Min3, C. Ahn4

  • Involvement of Genetic Variation and Related Gene Expression Changes on Acute Rejection in Renal Transplant Recipients

    H. Hwang1, J. Seo1, J. Kim1, Y. Kim1, J. Moon1, K. Jeong1, C. Kim2, J. Park3, B. Chung4, Y. Kim5, S. Lee1

  • Is Alemtuzumab Induction Safe In Septuagenarians Undergoing Deceased Donor Kidney Transplantation?

    D. Harriman, V. Gurram, C. Jay, J. Rogers, A. Farney, G. Orlando, A. Reeves-Daniel, A. Mena-Gutierrez, R. Stratta

  • Is Bariatric Surgery Feasible in the Setting of Liver and Kidney Transplants?

    L. M. Potter, A. Saharia, C. Mobley, K. Lunsford, M. Hobeika, N. Tariq, H. Podder, A. O. Gaber, R. M. Ghobrial

  • Is Exposure to Wildfires Associated with Invasive Fungal Infections?

    J. S. Mulliken1, A. G. Rappold2, M. Fung1, J. M. Babik1, S. B. Doernberg1

  • Is HLA Donor-Specific Antibody (DSA)-C3d+ Assay a Potential Predictor of Subclinical Antibody Mediated Damage in the Renal Graft?

    A. G. Contreras1, M. I. Solis-G1, C. Ramirez-Espinoza1, J. Hernandez-Rosales2, M. Vilatoba-Chapa1, R. Cruz-Martínez1, J. Granados1, L. E. Morales-Buenrostro3, J. Alberú1, J. M. Arreola-Guerra4

  • Is Kidney Transplantation Actually a Cost-Effective Alternative Also for Older Patients?

    K. Heldal1, K. Lønning2, V. Tsarpali1, K. Midtvedt2

  • Is Living Donor Kidney Donor Profile Index Useful for Japanese?

    K. Okumura1, K. Tanaka2, Y. Hidaka2, M. Toyoda3, S. Uekihara3, A. Inadome4, H. Yokomizo2, S. Yamanaga2

  • Is Muscular Dystrophy A Contraindication To Heart Transplantation?

    M. Kittleson, J. Patel, D. H. Chang, S. Dimbil, R. Levine, L. Czer, J. A. Kobashigawa

  • Is Narrative Storytelling Ethical to Use to Educate the Public about Living Donation? Transplant Professionals Weigh In

    W. Balliet1, L. Holland-Carter1, S. N. Maurer1, M. P. Salas1, C. S. Anderson2, O. N. Ranasinghe2, A. D. Waterman2

  • Is Pre-transplant Plasmapheresis For Patients With Insignificant Abo Blood Type Antibody In Abo Blood Type Incompatible Kidney Transplant Necessary? – A Japanese Single Center Study.

    M. Miyazaki, A. Mitsuke, H. Higuchi, N. Fukuzawa, H. Tanaka, T. Hirano, T. Seki, H. Harada

  • Ischemia-Free Liver Transplantation Protects Bile Duct from Ischemia/Reperfusion Injury

    J. Yang, S. Huang, Z. Zhang, Q. Zhao, W. Ju, Z. Zhu, Y. Tang, L. Wang, Y. Zhang, C. Sun, L. Wu, Z. Guo, X. He

  • Ischemic Preconditioning Attenuates Renal Ischemia-Reperfusion Injury through Activating the Nrf2/HO-1 Pathway Enhanced Autophagy

    H. Choi1, Y. Kim2, M. Kim2, K. Jun2, S. Kim2, S. Park3, J. Kim4, I. Moon5, J. Hwang6

  • Islet Stress Leads to Increased Release of Exosomes That Stimulate Immune Cell Response

    S. Vasu1, C. Darden2, K. Kumano1, B. Naziruddin3, M. Lawrence3

  • Islet Xenotransplantation: A Quest for Clinically Available Immunosuppression Regimens

    Z. W. Fitch1, Q. Gao1, R. P. Davis1, M. S. Mulvihill1, M. Song1, F. Leopardi1, M. Ribeiro1, T. How1, K. Reimann2, G. R. Devi1, B. H. Collins1, A. D. Kirk1

Jump to:  View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences